| Brandon Willem Vanderwel, MD | |
|
19930 Ballinger Way Ne, Shoreline, WA 98155-1223 | |
| (425) 778-2220 | |
| Not Available |
| Full Name | Brandon Willem Vanderwel |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 19930 Ballinger Way Ne, Shoreline, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144667858 | NPI | - | NPPES |
| MD60786062 | Other | WA | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD60786062 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brandon Willem Vanderwel, MD 1965 Coulston St Apt 14, Loma Linda, CA 92354-1741 Ph: () - | Brandon Willem Vanderwel, MD 19930 Ballinger Way Ne, Shoreline, WA 98155-1223 Ph: (425) 778-2220 |
News Archive
A multidisciplinary group of researchers from British Columbia has developed a participatory action research program to help address healthy body weight in children.
in collaboration with Parkland Health and Hospital System, Texas Health Resources, VA North Texas Health Care System, and ProHealth Physicians, Inc. of Connecticut - will lead the first National Institutes of Health-funded, multicenter, clinical trial to address interventions for patients with multiple chronic conditions centered around kidney disease.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 9 days ago
Dr. Jedediah A Kaufman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 19930 Ballinger Way Ne, Shoreline, WA 98155 Phone: 425-778-2220 | |
Dr. Sigrid Pakula Guyton, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 Nw Highland Dr, The Highlands, 111, Shoreline, WA 98177 Phone: 206-365-1479 | |
Alvina Won, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 19930 Ballinger Way Ne, Shoreline, WA 98155 Phone: 425-778-2220 | |
Lancy Mimi Tan, MD Surgery Medicare: Medicare Enrolled Practice Location: 19930 Ballinger Way Ne, Shoreline, WA 98155 Phone: 425-778-2220 Fax: 425-778-7701 | |
Dr. Kurtis Alan Stewart, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 19930 Ballinger Way Ne, Shoreline, WA 98155 Phone: 425-778-2220 | |
Robert W Landerholm, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 19930 Ballinger Way Ne, Shoreline, WA 98155 Phone: 425-778-2220 |